<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06050000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P43403</UniProt_ID>
  <Seq_Length>619</Seq_Length>
  <Molecule_Weight>69872</Molecule_Weight>
  <KEGG_ID>hsa:7535</KEGG_ID>
  <Orthology_ID>K07360</Orthology_ID>
  <EBI_ID>EBI-1211276</EBI_ID>
  <Function_Summary>Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR).</Function_Summary>
  <Catalytic_Mechanism>ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF07714:Pkinase_Tyr@@PF00017:SH2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>70 kDa zeta-chain associated protein</Alias>
      <Alias>Syk-related tyrosine kinase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a non-membrane spanning protein L-tyrosine = ADP + a non-membrane spanning protein L-tyrosine phosphate.</Detail>
      <Keyword>Non-membrane spanning protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004715</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.</Detail>
      <Keyword>Protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004713</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>523</Position>
      <Original>Trp</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>465</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>518</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>465</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>507</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>448</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>564</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A series of reactions that occur within the cell, mediated by protein kinases, which occurs as a result of a single trigger reaction or compound.</Detail>
      <Keyword>Intracellular protein kinase cascade</Keyword>
      <Ontology_ID>GO:0007243</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.</Detail>
      <Keyword>T cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050852</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of sparing immature T cells in the thymus which react with self-MHC protein complexes with low affinity levels from apoptotic death.</Detail>
      <Keyword>Positive thymic T cell selection</Keyword>
      <Ontology_ID>GO:0045059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in adaptive immunity. Vertebrates can develop a broad and almost infinite repertoire of antigen-specific receptors, which allows vertebrates to recognize almost any potential pathogen or toxin and to mount antigen-specific responses to it. Two types of adaptive immunity systems have evolved in vertebrates in order to generate immune receptor diversity. The jawed vertebrates strategy uses the V(D)JC recombination to achieve combinatorial diversity of immunoglobulin-based B cell receptors and T cell receptors. The jawless vertebrate strategy uses the somatic rearrangements of variable leucine-rich cassettes in the variable lymphocyte receptors (VLRs). The hallmarks of an adaptive immune system is the production of antigen-specific recognition receptor by somatic gene rearrangement. The long life of some antigen-primed cytotoxic lymphocytes and plasma cells provide protective memory to prevent reinvasion.</Detail>
      <Keyword>Adaptive immunity</Keyword>
      <Ontology_ID>KW-1064</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a T cell within or between different tissues and organs of the body.</Detail>
      <Keyword>T cell migration</Keyword>
      <Ontology_ID>GO:0072678</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The adhesion of one T cell to one or more other T cells via adhesion molecules.</Detail>
      <Keyword>T cell aggregation</Keyword>
      <Ontology_ID>GO:0070489</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.</Detail>
      <Keyword>B cell activation</Keyword>
      <Ontology_ID>GO:0042113</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process, and allowing for enhanced response to subsequent exposures to the same antigen (immunological memory).</Detail>
      <Keyword>Adaptive immune response</Keyword>
      <Ontology_ID>GO:0002250</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of T cell differentiation.</Detail>
      <Keyword>Positive regulation of T cell differentiation</Keyword>
      <Ontology_ID>GO:0045582</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>319</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>292</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>315</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>603</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>492</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>493</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>248</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>289</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPDPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVYESPYSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGPPGSTQKAEAACA</Protein_Seq>
    <DNA_Seq>AATAGGTTAGTTTCAGACAAGCCTGCTTGCCGGAGCTCAGCAGACACCAGGCCTTCCGGGCAGGCCTGGCCCACCGTGGGCCTCAGAGCTGCTGCTGGGGCATTCAGAACCGGCTCTCCATTGGCATTGGGACCAGAGACCCCGCAAGTGGCCTGTTTGCCTGGACATCCACCTGTACGTCCCCAGGTTTCGGGAGGCCCAGGGGCGATGCCAGACCCCGCGGCGCACCTGCCCTTCTTCTACGGCAGCATCTCGCGTGCCGAGGCCGAGGAGCACCTGAAGCTGGCGGGCATGGCGGACGGGCTCTTCCTGCTGCGCCAGTGCCTGCGCTCGCTGGGCGGCTATGTGCTGTCGCTCGTGCACGATGTGCGCTTCCACCACTTTCCCATCGAGCGCCAGCTCAACGGCACCTACGCCATTGCCGGCGGCAAAGCGCACTGTGGACCGGCAGAGCTCTGCGAGTTCTACTCGCGCGACCCCGACGGGCTGCCCTGCAACCTGCGCAAGCCGTGCAACCGGCCGTCGGGCCTCGAGCCGCAGCCGGGGGTCTTCGACTGCCTGCGAGACGCCATGGTGCGTGACTACGTGCGCCAGACGTGGAAGCTGGAGGGCGAGGCCCTGGAGCAGGCCATCATCAGCCAGGCCCCGCAGGTGGAGAAGCTCATTGCTACGACGGCCCACGAGCGGATGCCCTGGTACCACAGCAGCCTGACGCGTGAGGAGGCCGAGCGCAAACTTTACTCTGGGGCGCAGACCGACGGCAAGTTCCTGCTGAGGCCGCGGAAGGAGCAGGGCACATACGCCCTGTCCCTCATCTATGGGAAGACGGTGTACCACTACCTCATCAGCCAAGACAAGGCGGGCAAGTACTGCATTCCCGAGGGCACCAAGTTTGACACGCTCTGGCAGCTGGTGGAGTATCTGAAGCTGAAGGCGGACGGGCTCATCTACTGCCTGAAGGAGGCCTGCCCCAACAGCAGTGCCAGCAACGCCTCAGGGGCTGCTGCTCCCACACTCCCAGCCCACCCATCCACGTTGACTCATCCTCAGAGACGAATCGACACCCTCAACTCAGATGGATACACCCCTGAGCCAGCACGCATAACGTCCCCAGACAAACCGCGGCCGATGCCCATGGACACGAGCGTGTATGAGAGCCCCTACAGCGACCCAGAGGAGCTCAAGGACAAGAAGCTCTTCCTGAAGCGCGATAACCTCCTCATAGCTGACATTGAACTTGGCTGCGGCAACTTTGGCTCAGTGCGCCAGGGCGTGTACCGCATGCGCAAGAAGCAGATCGACGTGGCCATCAAGGTGCTGAAGCAGGGCACGGAGAAGGCAGACACGGAAGAGATGATGCGCGAGGCGCAGATCATGCACCAGCTGGACAACCCCTACATCGTGCGGCTCATTGGCGTCTGCCAGGCCGAGGCCCTCATGCTGGTCATGGAGATGGCTGGGGGCGGGCCGCTGCACAAGTTCCTGGTCGGCAAGAGGGAGGAGATCCCTGTGAGCAATGTGGCCGAGCTGCTGCACCAGGTGTCCATGGGGATGAAGTACCTGGAGGAGAAGAACTTTGTGCACCGTGACCTGGCGGCCCGCAACGTCCTGCTGGTTAACCGGCACTACGCCAAGATCAGCGACTTTGGCCTCTCCAAAGCACTGGGTGCCGACGACAGCTACTACACTGCCCGCTCAGCAGGGAAGTGGCCGCTCAAGTGGTACGCACCCGAATGCATCAACTTCCGCAAGTTCTCCAGCCGCAGCGATGTCTGGAGCTATGGGGTCACCATGTGGGAGGCCTTGTCCTACGGCCAGAAGCCCTACAAGAAGATGAAAGGGCCGGAGGTCATGGCCTTCATCGAGCAGGGCAAGCGGATGGAGTGCCCACCAGAGTGTCCACCCGAACTGTACGCACTCATGAGTGACTGCTGGATCTACAAGTGGGAGGATCGCCCCGACTTCCTGACCGTGGAGCAGCGCATGCGAGCCTGTTACTACAGCCTGGCCAGCAAGGTGGAAGGGCCCCCAGGCAGCACACAGAAGGCTGAGGCTGCCTGTGCCTGAGCTCCCGCTGCCCAGGGGAGCCCTCCACGCCGGCTCTTCCCCACCCTCAGCCCCACCCCAGGTCCTGCAGTCTGGCTGAGCCCTGCTTGGTTGTCTCCACACACAGCTGGGCTGTGGTAGGGGGTGTCTCAGGCCACACCGGCCTTGCATTGCCTGCCTGGCCCCCTGTCCTCTCTGGCTGGGGAGCAGGGAGGTCCGGGAGGGTGCGGCTGTGCAGCCTGTCCTGGGCTGGTGGCTCCCGGAGGGCCCTGAGCTGAGGGCATTGCTTACACGGATGCCTTCCCCTGGGCCCTGACATTGGAGCCTGGGCATCCTCAGGTGGTCAGGCGTAGATCACCAGAATAAACCCAGCTTCCCTCTTGAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Pro/pre B-cells</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Early thymocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Natural killer cells</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>T-cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>T cell receptor complex</CellLocal>
      <Ontology_ID>GO:0042101</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ZAP70</Gene_Name>
    <Gene_Alias>SRK</Gene_Alias>
    <Gene_ID>7535</Gene_ID>
    <Genbank_ACCN>NM_001079</Genbank_ACCN>
    <Protein_ACCN>NP_001070</Protein_ACCN>
    <HGNC_ID>12858</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7535</Gene_URL>
    <UCSC_ID>uc002sye.1</UCSC_ID>
    <EMBL_ID>ENSG00000115085</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9Y2R2</Uniprot_ID>
      <Gene_Name>PTPN22</Gene_Name>
      <EBI_ID>EBI-1211241</EBI_ID>
      <PPI_EBI_URL>EBI-1211276,EBI-1211241</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Severe Combined Immunodeficiency</Disease_Name>
      <Disease_Detail>Severe Combined Immunodeficiency</Disease_Detail>
      <Disease_DB>SVR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_combined_immunodeficiency?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Macroglobulinemia</Disease_Name>
      <Disease_Detail>Macroglobulinemia</Disease_Detail>
      <Disease_DB>MCR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/macroglobulinemia?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malt Lymphoma</Disease_Name>
      <Disease_Detail>Malt Lymphoma</Disease_Detail>
      <Disease_DB>MLT022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malt_lymphoma?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Zap-70 Deficiency</Disease_Name>
      <Disease_Detail>Zap-70 Deficiency</Disease_Detail>
      <Disease_DB>ZP7002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/zap_70_deficiency?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cd8 Deficiency, Familial</Disease_Name>
      <Disease_Detail>Cd8 Deficiency, Familial</Disease_Detail>
      <Disease_DB>CD8002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cd8_deficiency_familial?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Waldenstrom Macroglobulinemia</Disease_Name>
      <Disease_Detail>Waldenstrom Macroglobulinemia</Disease_Detail>
      <Disease_DB>WLD002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/waldenstrom_macroglobulinemia?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prolymphocytic Leukemia</Disease_Name>
      <Disease_Detail>Prolymphocytic Leukemia</Disease_Detail>
      <Disease_DB>PRL017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prolymphocytic_leukemia?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cll/sll</Disease_Name>
      <Disease_Detail>Cll/sll</Disease_Detail>
      <Disease_DB>CLL014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cll_sll?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Lymphocytic Leukemia</Disease_Name>
      <Disease_Detail>Chronic Lymphocytic Leukemia</Disease_Detail>
      <Disease_DB>CHR090</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_lymphocytic_leukemia?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Zap70-Related Severe Combined Immunodeficiency</Disease_Name>
      <Disease_Detail>Zap70-Related Severe Combined Immunodeficiency</Disease_Detail>
      <Disease_DB>ZP7001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/zap70_related_severe_combined_immunodeficiency?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Nasopharyngeal Angiofibroma</Disease_Name>
      <Disease_Detail>Juvenile Nasopharyngeal Angiofibroma</Disease_Detail>
      <Disease_DB>JVN033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_nasopharyngeal_angiofibroma?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Lymphoblastic Leukemia</Disease_Name>
      <Disease_Detail>Acute Lymphoblastic Leukemia</Disease_Detail>
      <Disease_DB>ACT101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_lymphoblastic_leukemia?search=ZAP70#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Combined Immunodeficiency, Atypical</Disease_Name>
      <Disease_Detail>Severe Combined Immunodeficiency</Disease_Detail>
      <Disease_DB>SVR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_combined_immunodeficiency_atypical?search=ZAP70#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Tandem SH2 domains of ZAP-70 with 19-mer zeta1 peptide</PDB_Title>
      <PDB_ID>2OQ1</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OQ1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular basis for the interaction of ZAP-70 with the T-cell receptor</PubMed_Title>
      <Author>Hatada, M.H., et al.</Author>
      <Journal>Nature(1995)377:32-38</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7659156?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of c-Cbl-ZAP-70 peptide complex</PDB_Title>
      <PDB_ID>2Y1N</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2Y1N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for Autoinhibition and Phosphorylation-Dependent Activation of C-Cbl.</PubMed_Title>
      <Author>Dou, H., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2012)19:184</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22266821?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF A CBL-UBCH7 COMPLEX: RING DOMAIN FUNCTION IN UBIQUITIN-PROTEIN LIGASES</PDB_Title>
      <PDB_ID>1FBV</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FBV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.</PubMed_Title>
      <Author>Zheng, N., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2000)102:533-539</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10966114?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Autoinhibited intact human ZAP-70</PDB_Title>
      <PDB_ID>2OZO</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OZO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70.</PubMed_Title>
      <Author>Deindl, S., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2007)129:735-746</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17512407?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine</PDB_Title>
      <PDB_ID>1U59</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1U59</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Three-dimensional Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine: IMPLICATIONS FOR THE DESIGN OF SELECTIVE INHIBITORS</PubMed_Title>
      <Author>Jin, L., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:42818-42825</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15292186?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70</PDB_Title>
      <PDB_ID>2CBL</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CBL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of modified phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex</PDB_Title>
      <PDB_ID>4A4B</PDB_ID>
      <Resolution>2.79</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4A4B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for Autoinhibition and Phosphorylation-Dependent Activation of C-Cbl</PubMed_Title>
      <Author>Dou, H., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2012)19:184</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22266821?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the apo SH2 domains of ZAP-70</PDB_Title>
      <PDB_ID>1M61</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M61</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem</PubMed_Title>
      <Author>Folmer, R.H.A., et al.</Author>
      <Journal>Biochemistry(2002)41:14176-14184</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12450381?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex</PDB_Title>
      <PDB_ID>4A4C</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4A4C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for Autoinhibition and Phosphorylation-Dependent Activation of C-Cbl</PubMed_Title>
      <Author>Dou, H., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2012)19:184</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22266821?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04660</Pathway_ID>
      <Pathway_Title>T cell receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04650</Pathway_ID>
      <Pathway_Title>Natural killer cell mediated cytotoxicity</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05340</Pathway_ID>
      <Pathway_Title>Primary immunodeficiency</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Immune diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ei.b.b.ba.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1fbv</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.10.2</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/10/2.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>